In the wake of the Johnson & Johnson’s settlements over its improper marketing of Risperdal, Forbes magazine comments on the company’s “vulnerable and now broken – image.” Read moreDiscuss →
[wpc_comments_count]
***
Mad in America hosts blogs by a diverse group of writers. These posts are designed to serve as a public forum for a discussion—broadly speaking—of psychiatry and its treatments. The opinions expressed are the writers’ own.
